Status:
COMPLETED
Tele-Physiotherapy After COVID-19 Hospitalization
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Covid19
Coronavirus Disease 2019
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), is a multisystem infectious disease which has led to a global pandemic. Tele-medicine is a...
Detailed Description
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), is a multisystem infectious disease which has led to a global pandemic. Due to multisystem...
Eligibility Criteria
Inclusion
- Discharged patients with Covid-19 pneumonia,
- Having at least one rT-PCR Covid test,
- Duration of hospitalization \> 10 days,
- Ability to walk,
- Totally oriented,
- Ability to use smartphone,
- Ability to read and write in Persian.
Exclusion
- Having any kind of musculoskeletal disorder causing inability to participate in physiotherapy sessions,
- Severe cardiovascular impairments.
Key Trial Info
Start Date :
June 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04895371
Start Date
June 12 2021
End Date
April 30 2022
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imam Khomeini Hospital Complex
Tehran, Iran